ES2172690T3 - Compuestos de mercaptoalquilpeptidil con un sustituyente de imidazol y su utilizacion como inhibidores de metaloproteinasas de matriz (mmp) y/o del factor de necrosis tumoral (tnf). - Google Patents
Compuestos de mercaptoalquilpeptidil con un sustituyente de imidazol y su utilizacion como inhibidores de metaloproteinasas de matriz (mmp) y/o del factor de necrosis tumoral (tnf).Info
- Publication number
- ES2172690T3 ES2172690T3 ES96939208T ES96939208T ES2172690T3 ES 2172690 T3 ES2172690 T3 ES 2172690T3 ES 96939208 T ES96939208 T ES 96939208T ES 96939208 T ES96939208 T ES 96939208T ES 2172690 T3 ES2172690 T3 ES 2172690T3
- Authority
- ES
- Spain
- Prior art keywords
- rent
- heteroarilo
- arilo
- imidazol
- substitute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108060008682 Tumor Necrosis Factor Proteins 0.000 title abstract 3
- 102000003390 tumor necrosis factor Human genes 0.000 title abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000011159 matrix material Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
COMPUESTOS DE PEPTIDILO QUE LLEVAN UN SUSTITUYENTE DE IMIDAZOL DE FORMULA GENERAL (I), EN DONDE R 1 ES ALQUILO DE C 16 , ALQUENILO DE C 2-6 , ALQUIL-ARILO (EL ALQUILO DE C 16 ), ARILO, ALQUIL-HETEROARILO (EL ALQUILO DE C 1-6 ), HETEROARILO O ALQUIL-AR 9 (EL ALQUILO DE C 1-6 , DONDE A ES O, NR 9 O S(O) M , SIENDO M = 0-2, Y R SUP,9 ES H, ALQUILO DE C 1-4 , ARILO, HETEROARILO, ALQUIL-AR ILO (EL ALQUILO DE C 1-4 ) O ALQUIL-HETEROARILO (EL ALQUILO DE C 1-4 ); SI A = NR 9 EL GRUPO R 9 PUEDE SER EL MISMO O DIFERENTE; R 2 ES HIDROGENO O UN GRUPO ALQUILO DE C 1-6 ; R 3 ES UN GRUPO [ALQ] N R 6 EN DONDE ALQ ES UN ALQUILO DE C 1-6 O ALQUENILO DE C 2-6 Y N ES CERO O 1; X ES NR 9 , O O S; Y ES N O CR 4 ; R SUP,4 Y R 5 SON IGUALES O DIFERENTES Y SON R 9 , COR 13 ALQUIL - R 13 (EL ALQUILO DE C 1-3 ) O ALQUILCOR 13 (EL ALQUILO DE C 1-3 ); R 7 ES HIDROGENO O R 10 CO, EN DONDE R 10 ES ALQUILO DE C 1-4 , ALQUILARILO (EL ALQUILO DE C 1-4 , ALQUIL-HETEROARILO (EL AL QUILO DE C 1-4 , CICLOALQUILO DE C 3-6 , ALQUIL-CICLOALQUILO (EL PRIMER ALQUILO DE C 1-4 , EL CICLOALQUILO DE C SUB,3-6 , ALQUENILO DE C 2-6 , ALQUENIL-ARILO DE C 2-6, ARILO O HETEROARILO; R 8 ES ARILO (OPCIONALMENTE SUSTI TUIDO CON R 11 ), HETEROARILO (OPCIONALMENTE SUSTITUIDO CON R 11 ), ALQUILO DE C 1-4 (OPCIONALMENTE SUSTITUIDO CON R 11 , ETC; TIENEN UNA UTILIDAD TERAPEUTICA MEDIANTE SU EFECTO INHIBIDOR SOBRE LAS METALOPROTEINASAS Y SOBRE EL FACTOR DE NECROSIS TUMORAL.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523828.3A GB9523828D0 (en) | 1995-11-22 | 1995-11-22 | Compounds |
| GBGB9607121.2A GB9607121D0 (en) | 1996-04-04 | 1996-04-04 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2172690T3 true ES2172690T3 (es) | 2002-10-01 |
Family
ID=26308152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96939208T Expired - Lifetime ES2172690T3 (es) | 1995-11-22 | 1996-11-22 | Compuestos de mercaptoalquilpeptidil con un sustituyente de imidazol y su utilizacion como inhibidores de metaloproteinasas de matriz (mmp) y/o del factor de necrosis tumoral (tnf). |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6048841A (es) |
| EP (1) | EP0874842B1 (es) |
| JP (1) | JP2000500482A (es) |
| KR (1) | KR19990067687A (es) |
| CN (1) | CN1072667C (es) |
| AT (1) | ATE215946T1 (es) |
| AU (1) | AU711907B2 (es) |
| BR (1) | BR9611636A (es) |
| CA (1) | CA2229438C (es) |
| CZ (1) | CZ291337B6 (es) |
| DE (1) | DE69620639T2 (es) |
| ES (1) | ES2172690T3 (es) |
| HU (1) | HUP9904131A3 (es) |
| IL (1) | IL123431A (es) |
| MX (1) | MX9804052A (es) |
| NO (1) | NO982290D0 (es) |
| NZ (1) | NZ322565A (es) |
| PL (1) | PL326710A1 (es) |
| WO (1) | WO1997019075A1 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
| US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| RU2201931C2 (ru) | 1996-11-20 | 2003-04-10 | Биомежер Инкорпорэйтед | Ингибиторы фарнезилтрансферазы и способы ингибирования фарнезилтрансферазы |
| CA2876779A1 (en) | 2000-05-12 | 2001-11-22 | Genzyme Corporation | Modulators of tnf-.alpha. signaling |
| ES2208595T3 (es) | 2000-05-15 | 2004-06-16 | Darwin Discovery Limited | Derivados del acido hidroxamico. |
| SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
| CN100503608C (zh) * | 2002-01-07 | 2009-06-24 | 卫材R&D管理株式会社 | 脱氮嘌呤及其用途 |
| SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
| GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
| ES2363914T3 (es) * | 2002-11-21 | 2011-08-19 | Genzyme Corporation | Utilización de un derivado de diamida para inhibir el rechazo crónico de un transplante. |
| US7217718B2 (en) * | 2002-11-21 | 2007-05-15 | Genzyme Corporation | Induction of immune tolerance |
| US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
| US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
| SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
| SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
| SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
| TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
| PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE150452T1 (de) * | 1992-04-07 | 1997-04-15 | British Biotech Pharm | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren |
| GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
| GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
| GB9404046D0 (en) * | 1994-03-03 | 1994-04-20 | Smithkline Beecham Corp | Novel compounds |
| CN1193978A (zh) * | 1994-10-05 | 1998-09-23 | 奇罗斯恩有限公司 | 肽基化合物和它们作为金属蛋白酶抑制剂的医疗用途 |
-
1996
- 1996-11-22 KR KR1019980703717A patent/KR19990067687A/ko not_active Application Discontinuation
- 1996-11-22 PL PL96326710A patent/PL326710A1/xx unknown
- 1996-11-22 AU AU76343/96A patent/AU711907B2/en not_active Ceased
- 1996-11-22 ES ES96939208T patent/ES2172690T3/es not_active Expired - Lifetime
- 1996-11-22 CA CA002229438A patent/CA2229438C/en not_active Expired - Fee Related
- 1996-11-22 CN CN96198507A patent/CN1072667C/zh not_active Expired - Fee Related
- 1996-11-22 HU HU9904131A patent/HUP9904131A3/hu unknown
- 1996-11-22 EP EP96939208A patent/EP0874842B1/en not_active Expired - Lifetime
- 1996-11-22 DE DE69620639T patent/DE69620639T2/de not_active Expired - Fee Related
- 1996-11-22 IL IL12343196A patent/IL123431A/en not_active IP Right Cessation
- 1996-11-22 US US08/755,071 patent/US6048841A/en not_active Expired - Fee Related
- 1996-11-22 BR BR9611636-6A patent/BR9611636A/pt unknown
- 1996-11-22 WO PCT/GB1996/002892 patent/WO1997019075A1/en not_active Application Discontinuation
- 1996-11-22 AT AT96939208T patent/ATE215946T1/de not_active IP Right Cessation
- 1996-11-22 CZ CZ19981455A patent/CZ291337B6/cs not_active IP Right Cessation
- 1996-11-22 JP JP9519522A patent/JP2000500482A/ja not_active Ceased
- 1996-11-22 NZ NZ322565A patent/NZ322565A/xx unknown
-
1998
- 1998-05-20 NO NO982290A patent/NO982290D0/no not_active Application Discontinuation
- 1998-05-21 MX MX9804052A patent/MX9804052A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL123431A0 (en) | 1998-09-24 |
| NO982290L (no) | 1998-05-20 |
| HUP9904131A3 (en) | 2002-04-29 |
| NO982290D0 (no) | 1998-05-20 |
| NZ322565A (en) | 1999-11-29 |
| WO1997019075A1 (en) | 1997-05-29 |
| AU711907B2 (en) | 1999-10-21 |
| DE69620639T2 (de) | 2002-10-17 |
| JP2000500482A (ja) | 2000-01-18 |
| CN1202895A (zh) | 1998-12-23 |
| MX9804052A (es) | 1998-09-30 |
| CZ291337B6 (cs) | 2003-02-12 |
| KR19990067687A (ko) | 1999-08-25 |
| CN1072667C (zh) | 2001-10-10 |
| CA2229438A1 (en) | 1997-05-29 |
| DE69620639D1 (de) | 2002-05-16 |
| EP0874842B1 (en) | 2002-04-10 |
| PL326710A1 (en) | 1998-10-26 |
| CZ145598A3 (cs) | 1998-08-12 |
| US6048841A (en) | 2000-04-11 |
| HUP9904131A2 (hu) | 2000-06-28 |
| AU7634396A (en) | 1997-06-11 |
| CA2229438C (en) | 2006-01-17 |
| ATE215946T1 (de) | 2002-04-15 |
| BR9611636A (pt) | 1999-12-28 |
| IL123431A (en) | 2001-05-20 |
| EP0874842A1 (en) | 1998-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2172690T3 (es) | Compuestos de mercaptoalquilpeptidil con un sustituyente de imidazol y su utilizacion como inhibidores de metaloproteinasas de matriz (mmp) y/o del factor de necrosis tumoral (tnf). | |
| AU9536898A (en) | 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein | |
| FI953748A (fi) | Yhdisteitä, joilla on sekä voimakas kalsium antagonisti- että antioksidanttiaktiivisuus sekä niiden käyttö solua suojaavina aineina | |
| KR930009607A (ko) | 증식성 질환의 치료를 위한 다이피리다몰 | |
| PL308217A1 (en) | Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells | |
| IL139056A0 (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
| BR0308339A (pt) | Indazóis substituìdos com uma atividade anticancerosa | |
| DE69928697D1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
| DE69725171D1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| BR9810366A (pt) | Derivados de ácido 4-bromo ou 4-iodo fenilamino benzidroxîmico e seu uso como inibidores de mek | |
| TR199900048T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler | |
| ES2174250T3 (es) | Inhibidores irreversibles de las quinasas de tirosina. | |
| NO991685L (no) | Anvendelse av 1-benzyl-3-(substituert hetaryl)-kondenserte pyrazolderivater for behandling av spesielle sykdommer i hjerte-kretsl°psystemet og sentralnervesystemet | |
| AU3110999A (en) | Disubstituted pyrazolines and triazolines as factor xa inhibitors | |
| DK0986382T3 (da) | RAF-kinasehæmmere | |
| IL136767A0 (en) | Inhibition of raf kinase using substituted heterocyclic ureas | |
| TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
| DE69711411D1 (de) | Verwendung von gamma-hydroxybuttersäureamiden in der behandlung von drogenabhängigkeit und insbesondere von alcoholismus | |
| NO975198L (no) | Tetralinforbindeler med MDR-aktivitet | |
| ATE336488T1 (de) | Neue ortho-naphthochinonderivate, neue synthesen zu ihrer herstellung und ihre anwendung in der inhibierung von neoplastischem zellwachstum | |
| PL330908A1 (en) | Inhibitors of prenyl transferases | |
| TR199900561T2 (xx) | G-protein i�levinin engellenmesi i�in ve �o�almaya y�nelik hastal�klar�n iyile�tirilmesi i�in yararl� trisiklik bile�ikler. | |
| CA2178528A1 (en) | Therapeutics Containing 5alpha - Reductase Inhibitors | |
| ATE231506T1 (de) | Tropanderivate insbesondere verwendbar zur detektion von dopamin transporters | |
| NO305556B1 (no) | Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 874842 Country of ref document: ES |